1. (CSDB ID: 51730) | ![]() |
{{{-a-D-Glcp-(1-4)-}}}a-D-Glcp-(1-6)-+ | {{{-a-D-Glcp-(1-4)-}}}a-D-Glcp-(1-6)-+ | | | -4)-{{{-a-D-Glcp-(1-4)-}}}/n=4/-a-D-Glcp-(1-4)-a-D-Glcp-(1-4)-a-D-Glcp-(1-4)-a-D-Glcp-(1-4)-a-D-Glcp-(1- | Show graphically |
Show legend Show as text |
Saccharomyces
(NCBI TaxID 4930,
species name lookup)
Recent advances on brewer's yeast cell wall polysaccharides have unraveled exquisite structural features and diverse composition with (β1→3), (β1→6), (α1→4), (β1→4)-mix-linked glucans that are recognized to interact with different cell receptors and trigger specific biological responses. Herein, a comprehensive showcase of structure-biofunctional relationships between yeast polysaccharides and their biological targets is highlighted, with a focus on polysaccharide features that govern the biomedical activity. The insolubility of β-glucans is a crucial factor for binding and activation of Dectin-1 receptor, operating as adjuvants of immune responses. Contrarily, soluble low molecular weight β-glucans have a strong inhibition of reactive oxygen species production, acting as antagonists of Dectin-1 mediated signaling. Soluble glucan-protein moieties can also act as antitumoral agents. The balance between mannoproteins-TLR2 and β-glucans-Dectin-1 receptors-activation is crucial for osteogenesis. Biomedical applications value can also be obtained from yeast microcapsules as oral delivery systems, where highly branched (β1→6)-glucans lead to higher receptor affinity.
drug delivery, beta-glucan, mannoprotein, brewer's spent yeast, microcapsule, regenerative medicine
Structure type: structural motif or average structure
2. (CSDB ID: 51731) | ![]() |
{{{-a-D-Glcp-(1-4)-}}}a-D-Glcp-(1-6)-+ {{{-b-D-Glcp-(1-3)-}}}b-D-Glcp-(1-6)-+ | | -4)-{{{-a-D-Glcp-(1-4)-}}}/n=5/-a-D-Glcp-(1-4)-a-D-Glcp-(1-4)-a-D-Glcp-(1-4)-a-D-Glcp-(1- | Show graphically |
Show legend Show as text |
Saccharomyces
(NCBI TaxID 4930,
species name lookup)
Recent advances on brewer's yeast cell wall polysaccharides have unraveled exquisite structural features and diverse composition with (β1→3), (β1→6), (α1→4), (β1→4)-mix-linked glucans that are recognized to interact with different cell receptors and trigger specific biological responses. Herein, a comprehensive showcase of structure-biofunctional relationships between yeast polysaccharides and their biological targets is highlighted, with a focus on polysaccharide features that govern the biomedical activity. The insolubility of β-glucans is a crucial factor for binding and activation of Dectin-1 receptor, operating as adjuvants of immune responses. Contrarily, soluble low molecular weight β-glucans have a strong inhibition of reactive oxygen species production, acting as antagonists of Dectin-1 mediated signaling. Soluble glucan-protein moieties can also act as antitumoral agents. The balance between mannoproteins-TLR2 and β-glucans-Dectin-1 receptors-activation is crucial for osteogenesis. Biomedical applications value can also be obtained from yeast microcapsules as oral delivery systems, where highly branched (β1→6)-glucans lead to higher receptor affinity.
drug delivery, beta-glucan, mannoprotein, brewer's spent yeast, microcapsule, regenerative medicine
Structure type: structural motif or average structureNew query | Export IDs | Home | Help |
Execution: 5 sec